CONCLUSIONS: Pediatricians do, in fact, document GU examinations on a routine basis. This finding allows surgical subspecialists like pediatric urologists to rest assured that, at the very least, the genitalia are being examined indicating that the most egregious pathology will be identified and referred appropriately. While our data demonstrated a lower than expected rate of UDT, this could indicate that although examinations are being performed, the accuracy of the examinations may be diminished due to lack of specialized training in the performance of genitourinary examination. Follow up studies are required to verify these potentially changing rates. 
INTRODUCTION AND OBJECTIVES:
The degree of bother caused by LUTS often guides treatment decisions. However, the relationship of LUTS severity and bother at the individual level and for individual symptoms is poorly understood. Aggregate measures are useful for evaluation of trends, but do not characterize individual variation. In this study, we evaluated individual variation of symptom severity and bother and characteristics of individuals with high LUTS bother.
METHODS: Men and women with LUTS seeking care at 6 tertiary care centers were enrolled in The Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Observational Cohort Study. Participants completed the LUTS Tool, which includes 22 LUTS severity and bother questions. Baseline LUTS tool responses were analyzed. Items were categorized into 6 groups based on symptom. Severity and bother components were separately summed within each group and normalized to range from 0 to 1. The discordance score (range -1 to 1) was calculated as the difference between the normalized severity and bother. Scores closer to 1 and -1 represent discordant symptoms where bother < severity or bother > severity, respectively, while scores close to 0 represent concordance between severity and bother. Patients were grouped into "high bother discordance", "low bother discordance", and "no discordance" groups. Multivariable logistic regression was used to identify characteristics associated with group membership in the high bother discordant group. RESULTS: Data were available for 1064 participants (519 men and 545 women). Across question groups, 6-27% of the cohort were in the high bother discordant group, 3-26% were in the low bother discordant group, and 68-87% were in the no discordant group (Figure 1) . In multivariable regression, female patients, black patients, increases in self-reported genitourinary pain, and depression scores were associated with higher odds of having a "high bother discordance". CONCLUSIONS: For all LUTS categories, there is variation amongst individuals in the degree of bother associated with severity of a given symptom. Identification of individuals with LUTS bother discordance may allow for the identification of associated phenotypes, which may be useful in determining those that may require an individualized treatment plan to address their LUTS.
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MP33-14 AN INVESTIGATION INTO HEALTH RELATED QUALITY OF LIFE OUTCOMES OF LOW-RISK PROSTATE CANCER PATIENTS TREATED WITH ACTIVE SURVEILLANCE VERSUS DEFINITIVE TREATMENT
Christopher C. Randall*, Mohamed H. Kamel, Mahmoud I. Khalil, L Joseph Su, Rodney Davis, Little Rock, AR INTRODUCTION AND OBJECTIVES: Active surveillance (AS) or definitive treatment (DT) in the form of surgery and radiation are treatment options for low risk prostate cancer (Pca). However, quality of life (QoL) outcomes of these options are poorly understood. We aim to study the QoL in low risk Pca patients who chose AS compared to DT using the Veterans RAND-12Ò (VR-12) QoL health survey.
METHODS: Low-risk Pca patients were identified through the Arkansas Central Cancer Registry. VR-12 health surveys were mailed to qualifying patients with follow-up phone calls to non-responders. The mental component score (MCS) and physical component score (PCS) together with the four distinct sub-scores of both MCS and PCS were analyzed and compared between the two groups. Supplementary questions were also administered in addition to the VR-12 survey including: age at diagnosis, education level, level of Urologist trust, and patient inclusion in the treatment decision. A multivariate regression model adjusted for these variables was
